{
  "docId": "019de076-567f-77cd-b2fe-46fe5b90ebce",
  "docSlug": "f071473f2318bf29da28de95df17ba43",
  "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
  "authorId": "matinas-biopharma",
  "authorName": "Matinas BioPharma",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 28,
  "pageCount": 31,
  "prevPage": 27,
  "nextPage": 29,
  "slideType": "timeline",
  "function": "plan_implementation",
  "density": "sparse",
  "nDataPoints": 0,
  "notes": "The slide uses a grid-based timeline layout to track multiple workstreams simultaneously.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-567f-77cd-b2fe-46fe5b90ebce/28",
  "deckHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce",
  "deckJsonHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce.json",
  "deckAnchorHref": "/decks/019de076-567f-77cd-b2fe-46fe5b90ebce#slide-28",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.84,
        "x": 0.13,
        "y": 0.26
      },
      "kind": "diagram",
      "text": "Visual bars representing ongoing activities and specific milestones across the timeline.",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aec613e7-cf03-4df6-b77e-1b6070002b85",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.78,
        "w": 0.96,
        "x": 0.02,
        "y": 0.17
      },
      "kind": "table",
      "text": "Timeline grid with rows for General Platform, Infection, Inflammation, Oncology and columns for quarters Q4 2022 through Q4 2023.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "00b1b72b-6735-4ef6-b824-26dc915a1ba0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.6,
        "x": 0.04,
        "y": 0.04
      },
      "kind": "title",
      "text": "Rapid Evolution of Platform Sets Stage for Active Q4",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "11040e2d-6d2c-4ba9-a136-cde3765ad9a5",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "dacb7508-a65a-4b9d-8413-f7068b2b6afa",
      "evidence": "The slide uses a horizontal bar-based timeline to track project milestones over time.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 29,
      "from": 27,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "d5dcfd9b-543a-4162-93c1-7a55c50880a6",
      "evidence": "Rapid Evolution of Platform Sets Stage for Active Q4 and Expanding LNC Intellectual Property Portfolio",
      "position": 1,
      "objective": "Explain why now is the right time for Matinas BioPharma",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.6,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}